HIV-1 Treatment: Long-Acting Cabotegravir and Rilpivirine for Older Adults

We are studying a new long-acting treatment for people aged 60 and older living with HIV-1. The goal is to see if it effectively controls the virus and how it affects overall health.

>2 years 11-15 visits Monitoring phase (IV)No Placebo Investigational Medicines InjectionInfectious DiseasesInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Rekambys

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Cabotegravir

Cabotegravir is a substance that helps treat and prevent HIV by blocking the virus from integrating into human DNA.

Rilpivirine

Rilpivirine is a substance used to treat HIV by stopping the virus from making copies of itself.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Vocabria

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Edurant

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Hospital General Universitario Dr. Balmis

Infectious Diseases

Alicante, Spain

Hospital General Universitario De Elche

Infectious Diseases

Elche, Spain

University Clinical Hospital Virgen De La Arrixaca

Infectious Diseases

Fuente-Álamo de Murcia, Spain

Sponsor: Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.